Results 231 to 240 of about 380,929 (303)

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi   +12 more
wiley   +1 more source

Trypanosomatid research in Brazil: a systematic analysis of regional and temporal trends. [PDF]

open access: yesMem Inst Oswaldo Cruz
Marinho B   +18 more
europepmc   +1 more source

Global Research Trends on Medial Meniscus Posterior Root Tear: A 20-Year Bibliometric Analysis. [PDF]

open access: yesJ Multidiscip Healthc
Zhu JW   +7 more
europepmc   +1 more source

Management accounting: a study in brazilian journals and spanish language

open access: yesRevista de Contabilidade e Organizações, 2011
Rogério João Lunkes   +2 more
doaj  

Home - About - Disclaimer - Privacy